Rallybio Stock (NASDAQ: RLYB) stock price, news, charts, stock research, profile.
Open | $1.610 |
Close | - |
Volume / Avg. | 234.318K / 1.593M |
Day Range | 1.540 - 1.685 |
52 Wk Range | 1.225 - 9.140 |
Market Cap | $69.840M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 4.43% |
Days to Cover | 10.7 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Rallybio (NASDAQ: RLYB) through any online brokerage.
Other companies in Rallybio’s space includes: Kezar Life Sciences (NASDAQ:KZR), Connect Biopharma Hldgs (NASDAQ:CNTB), CARISMA Therapeutics (NASDAQ:CARM), Eagle Pharmaceuticals (NASDAQ:EGRX) and Aligos Therapeutics (NASDAQ:ALGS).
The latest price target for Rallybio (NASDAQ: RLYB) was reported by JMP Securities on Friday, April 19, 2024. The analyst firm set a price target for 8.00 expecting RLYB to rise to within 12 months (a possible 374.78% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Rallybio (NASDAQ: RLYB) is $1.685 last updated Today at April 25, 2024 at 1:19 PM EDT.
There are no upcoming dividends for Rallybio.
Rallybio’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Rallybio.
Rallybio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.